title: The efficacy of daclizumab for intestinal transplantation: preliminary report.
authors.affiliation: Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. kae@med.pitt.edu
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: J
authors.initials: J
authors.lastname: Fung
authors.forename: W
authors.initials: W
authors.lastname: McGhee
authors.forename: D
authors.initials: D
authors.lastname: Martin
authors.forename: G
authors.initials: G
authors.lastname: Mazariegos
authors.forename: N
authors.initials: N
authors.lastname: Schaefer
authors.forename: J
authors.initials: J
authors.lastname: Demetris
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: J
authors.initials: J
authors.lastname: Reyes
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D000077561:Daclizumab; D005260:Female; D006084:Graft Rejection / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007422:Intestines / Q000473:pathology / Q000637:transplantation*; D008297:Male; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000077561:Daclizumab